Novavax Inc (NVAX)

$46.11 3.96 (7.91%)

19:59 EDT NVAX Stock Quote Delayed 30 Minutes

Volume:

Previous Close $4.60

Market Cap 17.60B

PE Ratio -75.59

EPS -0.61

Volume (Avg. Vol.) 6.08M

Day's Range 45.12 - 49.74

52-Week Range 3.54 - 61.50

Dividend & Yield N/A (N/A)

NVAX Stock Predictions, Articles, and Novavax Inc News

From InvestorPlace
From the Web

4 Top Stock Trades for Wednesday: UBER, ACB, NVAX, DKNG

By Bret Kenwell, InvestorPlace Contributor May 12, 2020

Uber, Novavax, DraftKings and Aurora Cannabis were our top stock trades for Wednesday. Let's have a look at what the charts say.

Novavax News: NVAX Stock Skyrockets 79% on COVID-19 Vaccine Funding

By William White, InvestorPlace Writer May 12, 2020

Novavax (NVAX) news for Tuesday concerning funding for a vaccine to stop the novel coronavirus has NVAX stock rocketing higher.

Novavax News: NVAX Stock Surges 14% as Human Trial for Coronavirus Vaccine Nears

By William White, InvestorPlace Writer Apr 8, 2020

Novavax (NVAX) news for Wednesday concerning a trial for a vaccine to treat the coronavirus from China has NVAX stock flying high.

How We “Flipped” a Beaten-Down Company for 126% Gains

By Jeff Clark, Market Minute Mar 31, 2020

Investors began buying up NVAX shares in anticipation of the Phase 3 clinical trial announcement. We wound up with a 130% gain on the trade.

5 Stocks to Buy That Are Holding Strong While Everything Else Crumbles

By Maya Sasson, Writer, TipRanks Mar 26, 2020

Unlike the broader market, these stocks to buy have managed to hold up strong amid the ongoing public health crisis.

7 “Perfect 10” Healthcare Stocks to Buy Now

By Maya Sasson, Writer, TipRanks Mar 18, 2020

Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.

Compare Brokers

Novavax Earnings: NVAX Stock Soars 8% on Strong Q4 Revenue Beat

By William White, InvestorPlace Writer Mar 11, 2020

Novavax (NVAX) earnings for the vaccine company's fiscal fourth quarter of 2019 have NVAX stock heading higher after-hours Wednesday.

Stock Market Today: Turnaround Tuesday; Tesla’s Big Milestone

By Bret Kenwell, InvestorPlace Contributor Mar 10, 2020

Tesla made its one-millionth car, while Delta expects to save $2 billion in fuel costs. Here's the stock market today.

3 Coronavirus Stocks to Own Until the Fear Fades

By Ian Cooper Feb 28, 2020

While most stocks and markets have taken big hits, these three coronavirus stocks have been among the most explosive opportunities.

Stock Market Today: Coronavirus Stokes Fear; Uber Stock Rallies

By Bret Kenwell, InvestorPlace Contributor Jan 21, 2020

Boeing shares tanked on more negative reports, while Uber rallied on an asset sale. Here's what happened in the stock market today.

Novavax News: NVAX Stock Skyrockets 52% on Mystery China Virus

By William White, InvestorPlace Writer Jan 21, 2020

Novavax (NVAX) news for Tuesday concerning the spread of a virus in China has NVAX stock heading higher as more investors pick up the stock.

5 “Strong Buy” Biotech Stocks With More Than 80% Upside

By Maya Sasson, Writer, TipRanks Nov 27, 2019

For investors seeking out the ultimate high-risk, high-reward stocks, look no further than the biotech industry.

Compare Brokers

Novavax News: Why NVAX Stock Is Shooting Higher Today

By William White, InvestorPlace Writer Jun 27, 2019

Novavax news for Thursday concerning an accelerated approval pathway for one of the company's drugs has NVAX stock soaring higher.

3 Cheap Stocks to Buy That Are Worth Every Penny

By Josh Enomoto, InvestorPlace Contributor Mar 22, 2019

With the major indices showing signs of hesitancy, now is an ideal time to consider lesser-known but viable cheap stocks.

Novavax News: Why NVAX Stock Is Plunging Today

By William White, InvestorPlace Writer Feb 28, 2019

Novavax news concerning the results from the company's recent trail of its drug ResVax has NVAX stock falling on Thursday.

Novavax Stock Is a Cautionary Tale for Speculators

By Bret Kenwell, InvestorPlace Contributor Feb 28, 2019

Novavax stock is plunging on Thursday after failing a Phase 3 study. That sets up a breakdown instead of a breakout in NVAX stock.

3 Penny Stocks Poised for Growth the Rest of 2018

By Will Healy, InvestorPlace Contributor Jun 13, 2018

These penny stocks are well-positioned for improving market conditions and possibly growth beyond penny stock status in the second half of 2018 and beyond.

3 Biotech Stocks That Will Thrive Amid Market Instability

By Zacks Investment Research Apr 19, 2018

The drugs/biotech sector has been down since the past month, reeling under broader market pressures. Only a few good stocks however, remain out of this rut. Com....

Compare Brokers

5 Big Biotech Stocks to Buy Under $10

By Aaron Levitt, InvestorPlace Contributor Mar 20, 2018

Small biotech stocks can pack a wallop. Here are five biotech stocks that have prospects bigger than their share prices.

Novavax (NVAX) Stock Upgraded to Buy

By Portfolio Grader Jan 23, 2018

As one of the 657 companies in the GICS Health Technology sector Novavax Inc (NASDAQ:NVAX) is a constituent of the 337 company Biotechnology GICS industry group within this sector. NVAX has a market value of $0.6 billion which is in the top half of its industry group. Portfolio Grader's current ranking for NVAX puts it 107 among the 337 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 213 among the 657 companies in the sector, and number 1,498 in the nearly 5,000 company Portfolio Grader universe.